Omega Therapeutics Stock (NASDAQ: OMGA) stock price, news, charts, stock research, profile.
Open | $2.400 |
Close | $2.470 |
Volume / Avg. | 404.685K / 378.213K |
Day Range | 2.350 - 2.550 |
52 Wk Range | 1.300 - 10.090 |
Market Cap | $139.542M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 51 |
Short Interest | 23.49% |
Days to Cover | 15.78 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Omega Therapeutics (NASDAQ: OMGA) through any online brokerage.
Other companies in Omega Therapeutics’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Molecular Partners (NASDAQ:MOLN), Renovaro (NASDAQ:RENB), CytomX Therapeutics (NASDAQ:CTMX) and Cellectar Biosciences (NASDAQ:CLRB).
The latest price target for Omega Therapeutics (NASDAQ: OMGA) was reported by HC Wainwright & Co. on Monday, May 13, 2024. The analyst firm set a price target for 12.00 expecting OMGA to rise to within 12 months (a possible 374.31% upside). 11 analyst firms have reported ratings in the last year.
The stock price for Omega Therapeutics (NASDAQ: OMGA) is $2.53 last updated Today at May 20, 2024 at 4:32 PM EDT.
There are no upcoming dividends for Omega Therapeutics.
Omega Therapeutics’s Q2 earnings are confirmed for Thursday, August 1, 2024.
There is no upcoming split for Omega Therapeutics.
Omega Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.